Skip to main content
Home

Leading research for life changing results

  • Our Role & Impact
    • About HMRI
    • Our Team
    • Research Funded through HMRI
    • Our Foundations
      • HMRI Foundation
      • HMRI Sydney Foundation
      • HCRF
      • HTRF
      • Borne HMRI
    • Awards and Recognition
      • Researcher Awards
      • HMRI Exceptional Service
    • Our Partnerships
    • Governance
    • Careers
    • Contact Us
  • Medical Research
    • Research
    • Researchers
    • Participate In Research
    • Coronavirus (COVID-19)
  • Support HMRI
    • Donate Online
    • Your Impact
    • Ways to Donate
    • Fundraise
    • Bequests
    • Volunteer
    • Company Donors
  • For Researchers
    • HMRI Connect Researcher Intranet
    • Services for Researchers
      • Clinical Trials Unit
      • Bioinformatics & Special Applications Support
      • Clinical Research Design and Statistics
      • Health Research Economists
      • Funding Support
      • Research Study Recruitment
      • Clinical Trials Roadmap
    • Facilities and Equipment for Researchers
    • Register to be a HMRI Researcher
  • Events
    • Upcoming Events
  • News & Articles
  1. Home
  2. Search Results

Search Results

  • All (9) Remove All (9) filter
  • News & Articles (4)
  • Research (3)
  • Researcher Profiles (2)

Search found 9 items

All
MicroRNA and antagomirs in the regulation and suppression of interferon (IFN)-g and lipopolysaccharide (LPS) induced steroid-resistant airways hyper reactivity
Category: Research
Research MicroRNA and antagomirs in the regulation and suppression of interferon (IFN)-g and lipopolysaccharide (LPS) induced ...
Anti-viral treatment bringing asthmatics in from the cold
Category: News & Articles
... cold. The international Phase 2 trial of a synthetic anti-viral ‘interferon’, inhaled via a nebuliser, proved most effective in helping ... they were then assessed within 24 hours and administered either the interferon or a placebo. The results, published in the American Journal ... looking for biomarker signatures. Professor Wark believes nebulised interferon could be applied to other patients with chronic respiratory ...
Molecular and cellular characterisation of TLR7 signalling in rhinovirus-induced asthma exacerbation
Category: Research
... of asthma exacerbations, which may be linked to an impaired antiviral interferon (IFN) response in asthmatics. RV is a single stranded (ss) ... attenuated RV clearance from the lungs. TLR7 deficiency also impaired interferon regulatory factor (IRF) 7 expression a master regulator of interferon responses in virus-induced asthma exacerbation in children ...
Su-Ling Loo
Category: Researcher Profiles
... replication within 24 hours of infection and also induced a strong interferon response from the epithelial cells. In contrast, OC43 reached ... this infection did not resolve. Interestingly OC43 did not induce an interferon response from the cells and this may suggest why its ...
Peter Wark
Category: Researcher Profiles
... common cold) with reduced release of a key immune response molecule, interferon (IFN)-β. The seminal finding that asthma can be associated with impaired interferon responses to rhinovirus has led to an international ...
Asthmatics more susceptible to cold virus infection
Category: News & Articles

Research Archive from 2006: A Hunter Medical Research Institute (HMRI) study has identified why asthmatics are more susceptible to the effects of the common cold which could lead to new treatments for acute asthma and health care savings.

Newcastle researchers help in the fight against STDs
Category: News & Articles
... and Jemma Mayall. The team discovered a protein, which they called Interferon epsilon (IFNe), and showed it plays an important role in ...
Cystic Fibrosis
Category: Research
... Researchers have also successfully trialled an inhaled drug (called interferon-β) in asthmatics which may interfere with viruses in the ...
$12.2m federal boost for vital research
Category: News & Articles
... Professor Phil Hansbro and his team to define the roles and targeting interferon-epsilon as a new therapy for influenza in asthma and COPD. ...
  • Contact us
  • View Research & Diseases
  • News & Articles
  • Site Map
  • Privacy Policy
  • ​
  • HUNTER MEDICAL RESEARCH INSTITUTE ABN 27 081 436 919 | Phone (02) 4042 0000 |  Donation Hotline 1300 993 822
  •  
  • Copyright © Hunter Medical Research Institute 2022
  •  
  • Tata Consultancy Services